Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B virus infection

The present invention relates to the fields of medicine and immunology. In particular, it relates to novel peptides that may be used in the treatment and/or prevention of a Hepatitis B viral infection and/or an Hepatitis B related disease or condition.

Saved in:
Bibliographic Details
Main Authors Kessler, Johan Herman, Krebber, Wilhelmus Johannes Theodorus Alexander, Melief, Cornelis Joseph Maria, Kwappenberg, Kitty Michelle Corinne
Format Patent
LanguageEnglish
Published 13.08.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the fields of medicine and immunology. In particular, it relates to novel peptides that may be used in the treatment and/or prevention of a Hepatitis B viral infection and/or an Hepatitis B related disease or condition.
Bibliography:Application Number: US201515315526